SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-23-095749
Filing Date
2023-12-14
Accepted
2023-12-14 16:37:15
Documents
3
Period of Report
2024-01-03

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT def14a1223_phoenixbio.htm DEF 14A 663384
2 GRAPHIC tproxy_001.jpg GRAPHIC 1573224
3 GRAPHIC tproxy_002.jpg GRAPHIC 1133840
  Complete submission text file 0001213900-23-095749.txt   4393595
Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450
PHOENIX BIOTECH ACQUISITION CORP. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40877 | Film No.: 231487556
SIC: 2836 Biological Products, (No Diagnostic Substances)